NDC Code(s) : 50383-924-93, 50383-930-93
Packager : Akorn Operating Company LLC (dba Akorn)
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : CIII
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
buprenorphine hydrochloridebuprenorphine hydrochloride TABLET | ||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
buprenorphine hydrochloridebuprenorphine hydrochloride TABLET | ||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||
|
LABELER - Akorn Operating Company LLC (dba Akorn)(117696873) |
REGISTRANT - Ethypharm Inc(256904426) |
PRINCIPAL DISPLAY PANEL
NDC 50383-924-93
30 Tablets
CIII
PHARMACIST: Dispense the Medication Guide to each patient.
Buprenorphine
Sublingual Tablets
2 mg*
Rx only
PRINCIPAL DISPLAY PANEL
NDC 50383-930-93
30 Tablets
CIII
PHARMACIST: Dispense the Medication Guide to each patient.
Buprenorphine
Sublingual Tablets
8 mg*
Rx only